How Your Body Clock Protein CLOCK Controls Aging and Cancer
The circadian CLOCK protein plays a dual role in cellular senescence — supporting healthy aging in normal cells while enabling tumor growth when hijacked.
Summary
Circadian rhythms do far more than regulate sleep. The CLOCK protein, a master regulator of the body's 24-hour cycle, directly influences cellular senescence, DNA repair, and aging. In healthy cells, CLOCK activates DNA repair factors like XPA and supports metabolic balance to slow aging. But in cancer cells, oncogenic drivers like c-MYC hijack CLOCK signaling to suppress senescence and fuel uncontrolled growth. Gut microbiota also interfere via aryl hydrocarbon receptor signals that disrupt the CLOCK-BMAL1 complex. CLOCK further interacts with mTOR and NF-κB pathways to regulate autophagy and limit damaging inflammatory secretions. This review synthesizes animal and human evidence to position CLOCK as a promising therapeutic target in both aging and cancer.
Detailed Summary
Circadian disruption — from shift work, irregular sleep, or metabolic dysfunction — is increasingly recognized as a driver of accelerated aging and age-related disease. Understanding the molecular machinery behind these effects is essential for developing targeted anti-aging interventions.
This 2025 review from researchers at Yangtze University and the University of Hradec Králové examines the specific role of the CLOCK protein in regulating cellular senescence. CLOCK is a core transcription factor in the circadian system that controls gene expression tied to tissue homeostasis, DNA integrity, and cell fate decisions.
The review reveals a compelling dual nature of CLOCK signaling. In normal, healthy cells, CLOCK promotes longevity-supporting processes: it activates DNA repair factors including XPA, modulates metabolism, and helps maintain tissue homeostasis. This positions CLOCK as a potential rejuvenating force at the cellular level. However, in tumor cells, oncogenic factors such as c-MYC and Pdia3 co-opt CLOCK signaling to inhibit telomere shortening and block senescence — effectively removing a natural brake on uncontrolled proliferation.
Beyond the cell-autonomous effects, CLOCK signaling is also influenced by the gut microbiome. Microbially produced aryl hydrocarbon receptor (AhR) ligands can disrupt the CLOCK-BMAL1 heterodimer complex, altering circadian gene expression. Separately, CLOCK interacts with the mTOR and NF-κB pathways to regulate autophagy and suppress harmful senescence-associated secretory phenotype (SASP) components that damage surrounding tissue.
The authors synthesize findings across animal models and human studies to argue that CLOCK represents a viable target for anti-aging therapies. Key caveats include the review's reliance on secondary analysis and the complexity of context-dependent CLOCK effects, which make straightforward therapeutic targeting challenging.
Key Findings
- CLOCK protein activates DNA repair factor XPA in normal cells, supporting cellular rejuvenation and slowing senescence.
- Oncogenes c-MYC and Pdia3 hijack CLOCK signaling in tumor cells to suppress senescence and drive uncontrolled growth.
- Gut microbiota-derived AhR signals disrupt the CLOCK-BMAL1 complex, linking microbiome health to circadian aging.
- CLOCK interacts with mTOR and NF-κB pathways to regulate autophagy and limit pro-inflammatory SASP secretions.
- CLOCK is proposed as a dual-role anti-aging and anti-cancer therapeutic target based on animal and human evidence.
Methodology
This is a narrative review synthesizing published animal and human studies on circadian CLOCK signaling and cellular senescence. No original experimental data were generated. Evidence is drawn from mechanistic molecular studies, cancer biology research, and aging models.
Study Limitations
As a review relying solely on the abstract, granular methodological details and the full scope of cited evidence cannot be assessed. CLOCK's context-dependent dual role in normal versus cancer cells complicates therapeutic targeting. Much of the mechanistic evidence comes from animal models, and human translation remains to be rigorously validated.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.